INITIATION OF T CELL IMMUNE RESPONSES IN GUT MUCOSA
肠道粘膜中 T 细胞免疫反应的启动
基本信息
- 批准号:3138236
- 负责人:
- 金额:$ 10.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-09-01 至 1991-12-31
- 项目状态:已结题
- 来源:
- 关键词:Peyer's patches T lymphocyte cellular immunity delayed hypersensitivity flow cytometry haptens helper T lymphocyte immunofluorescence technique interleukin 2 intestinal mucosa laboratory mouse leukocyte activation /transformation lymph nodes lymphokines nitrophenol passive immunization small intestines
项目摘要
We propose to examine in detail the participation and function of
different lymphoid cells in gut associated lymphoid tissues (GALT)
in the development of mucosal T cell-mediated responses of
delayed hypersensitivity (DH) and cell-mediated lympholysis
(CML) to orally administered hapten. We have chosen to study
these two T cell-mediated immune responses not only because
very little is known about their occurrence at the mucosal and
other organized lymphoid tissues of the gut, but also because
these responses may provide local protection against pathogenic
enteric viruses, bacteria, and parasites.
We will determine the time course of development of hapten
specific DH and cytotoxic T lymphocytes (CTL) in GALT as well
as changes in morphology and epithelial cell kinetics that occur in
small intestine after feeding hapten to the mice. Whether the
kinetics and the magnitude of these two responses can be altered
will be determined by pretreating animals with cyclophosphamide
or feeding the hapten more than once. The ability of purified
immune T cells isolated from GALT to adoptively transfer DH, to
develop hapten induced T cell proliferation, and to produce
migration inhibition factor (MIF) will be examined. Whether T
helper cells that assist in vivo DH induction are present in GALT
of hapten-fed animals will be examined by their ability to produce
hapten specific helper factor that aids development of in vivo DH
response. The phenotypic markers on the surface of GALT TDH
and TH(DH), hapten specificity and any genetic restriction of
their function will be examined.
The capacity of the GALT lymphocytes to generate CTLs and
produce lymphokines (interleukin 2 and differentiation factor)
that are required for the generation of CTLs in vitro will be
assessed. The frequencies of precursors of hapten specific CTLs
(p-CTL) and TH secreting IL2 among various lymphoid populations
of GALT will be determined by limiting dilution analysis (LDA).
The experimental work proposed here will allow us to acquire
information about functional capabilities of GALT lymphocytes in
the induction of mucosal T cell-mediated responses that may
provide protection against dietary and pathogenic antigens or that
may have adverse effects on the intestine.
我们建议详细研究
肠相关淋巴组织(GALT)中的不同淋巴细胞
在粘膜T细胞介导的反应的发展中,
迟发型超敏反应(DH)和细胞介导的淋巴细胞溶解
(CML)口服半抗原。 我们选择了学习
这两种T细胞介导的免疫反应不仅是因为
关于它们在粘膜中的发生知之甚少,
肠道的其他有组织淋巴组织,但也因为
这些反应可以提供局部保护,
肠道病毒、细菌和寄生虫。
我们将确定半抗原形成的时间过程
GALT中特异性DH和细胞毒性T淋巴细胞(CTL
由于在细胞内发生的形态学和上皮细胞动力学的变化,
给小鼠喂食半抗原后的小肠。 是否
这两种反应的动力学和大小可以改变
将通过用环磷酰胺预处理动物来确定
或多次饲喂半抗原。 净化能力
从GALT分离的免疫T细胞过继性转移DH,
发展半抗原诱导的T细胞增殖,并产生
将检查迁移抑制因子(MIF)。 是否T
辅助体内DH诱导的辅助细胞存在于GALT中
的半抗原喂养的动物将检查他们的能力,
有助于体内DH形成的半抗原特异性辅助因子
反应 GALT TDH表面的表型标记
和TH(DH)、半抗原特异性和任何遗传限制
将审查其职能。
GALT淋巴细胞产生CTL的能力和
产生淋巴因子(白细胞介素2和分化因子)
在体外产生CTL所需的细胞将被
评估。 半抗原特异性CTL的前体频率
(p-CTL)和TH分泌IL 2在不同的淋巴细胞群
将通过有限稀释分析(LDA)测定GALT。
这里提出的实验工作将使我们能够获得
关于GALT淋巴细胞功能的信息,
诱导粘膜T细胞介导的应答,
提供针对饮食和病原性抗原的保护,或者
可能会对肠道产生不良影响。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants.
介导对三硝基氯苯接触敏感性的 L3T4 (CD4 ) 细胞表达 I-A 决定簇。
- DOI:10.1016/0008-8749(91)90251-6
- 发表时间:1991
- 期刊:
- 影响因子:4.3
- 作者:Gautam,SC;Matriano,JA;Chikkala,NF;Edinger,MG;Tubbs,RR
- 通讯作者:Tubbs,RR
Differences in murine gut-associated lymphoid tissues in generating broadly nonspecific cytotoxic cells in response to interferon alpha A/D and interleukin 2.
小鼠肠道相关淋巴组织在响应干扰素 α A/D 和白细胞介素 2 时产生广泛非特异性细胞毒性细胞的差异。
- DOI:10.1016/0008-8749(91)90287-l
- 发表时间:1991
- 期刊:
- 影响因子:4.3
- 作者:Chikkala,NF;Gautam,SC
- 通讯作者:Gautam,SC
Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population.
口服接触敏化剂三硝基氯苯:初始敏化和随后出现抑制群。
- DOI:10.1016/0008-8749(90)90097-b
- 发表时间:1990
- 期刊:
- 影响因子:4.3
- 作者:Gautam,SC;Chikkala,NF;Battisto,JR
- 通讯作者:Battisto,JR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUBHASH C GAUTAM其他文献
SUBHASH C GAUTAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUBHASH C GAUTAM', 18)}}的其他基金
Mechanisms of Triterpenoids in Prevention of Prostate Cancer
三萜类化合物预防前列腺癌的机制
- 批准号:
8133866 - 财政年份:2008
- 资助金额:
$ 10.9万 - 项目类别:
Mechanisms of Triterpenoids in Prevention of Prostate Cancer
三萜类化合物预防前列腺癌的机制
- 批准号:
7899769 - 财政年份:2008
- 资助金额:
$ 10.9万 - 项目类别:
Mechanisms of Triterpenoids in Prevention of Prostate Cancer
三萜类化合物预防前列腺癌的机制
- 批准号:
7524417 - 财政年份:2008
- 资助金额:
$ 10.9万 - 项目类别:
Mechanisms of Triterpenoids in Prevention of Prostate Cancer
三萜类化合物预防前列腺癌的机制
- 批准号:
7664325 - 财政年份:2008
- 资助金额:
$ 10.9万 - 项目类别:
Curcumin/TRAIL Combination Therapy of Prostae Cancer
姜黄素/TRAIL联合治疗前列腺癌
- 批准号:
7034543 - 财政年份:2005
- 资助金额:
$ 10.9万 - 项目类别:
Curcumin/TRAIL Combination Therapy of Prostate Cancer
姜黄素/TRAIL联合治疗前列腺癌
- 批准号:
6917402 - 财政年份:2005
- 资助金额:
$ 10.9万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 10.9万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 10.9万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 10.9万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 10.9万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 10.9万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 10.9万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 10.9万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 10.9万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 10.9万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 10.9万 - 项目类别:
Discovery Grants Program - Individual